Emcure to make, market Roche products Hindu Business Line The second is Rituximab, sold as Mabthera, a drug for non-Hodgkin's lymphoma and rheumatoid arthritis. Similarly, this partnership will be extended to Roche's patented products in India currently sold under brand names Tarceva (for non-small cell lung ... |
